2OXN
Vibrio cholerae family 3 glycoside hydrolase (NagZ) in complex with PUGNAc
2OXN の概要
| エントリーDOI | 10.2210/pdb2oxn/pdb |
| 関連するPDBエントリー | 1TR9 1Y65 |
| 分子名称 | Beta-hexosaminidase, O-(2-ACETAMIDO-2-DEOXY D-GLUCOPYRANOSYLIDENE) AMINO-N-PHENYLCARBAMATE (3 entities in total) |
| 機能のキーワード | tim-barrel, hydrolase |
| 由来する生物種 | Vibrio cholerae |
| 細胞内の位置 | Cytoplasm (By similarity): Q9KU37 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 38241.36 |
| 構造登録者 | |
| 主引用文献 | Stubbs, K.A.,Balcewich, M.,Mark, B.L.,Vocadlo, D.J. Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance. J.Biol.Chem., 282:21382-21391, 2007 Cited by PubMed Abstract: The increasing spread of plasmid-borne ampC-ampR operons is of considerable medical importance, since the AmpC beta-lactamases they encode confer high level resistance to many third generation cephalosporins. Induction of AmpC beta-lactamase from endogenous or plasmid-borne ampC-ampR operons is mediated by a catabolic inducer molecule, 1,6-anhydro-N-acetylmuramic acid (MurNAc) tripeptide, an intermediate of the cell wall recycling pathway derived from the peptidoglycan. Here we describe a strategy for attenuating the antibiotic resistance associated with the ampC-ampR operon by blocking the formation of the inducer molecule using small molecule inhibitors of NagZ, the glycoside hydrolase catalyzing the formation of this inducer molecule. The structure of the NagZ-inhibitor complex provides insight into the molecular basis for inhibition and enables the development of inhibitors with 100-fold selectivity for NagZ over functionally related human enzymes. These PUGNAc-derived inhibitors reduce the minimal inhibitory concentration (MIC) values for several clinically relevant cephalosporins in both wild-type and AmpC-hyperproducing strains lacking functional AmpD. PubMed: 17439950DOI: 10.1074/jbc.M700084200 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.7 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






